Revised approach by EPO for Formal Entitlement for a Valid Priority Claim
(NEW ARTICLE) The recent decisions G1/22 and G2/22, issued by the Enlarged Board of Appeal (EBA), delve into the issue…
Read more Back to Home 
ZBM’s Laura Artigas participates in UB’s “Patent Mondays” with a conference on IP rights suitable for software and AI inventions and creations
On 29th May ZBM’s Laura Artigas held a lecture entitled ‘My client has developed software! IP rights…
Read moreSix paralegals in ZBM qualified with the EPAC certification!
We’re excited to announce that our colleagues from the formalities department Marga Ibáñez, Laura Santiago, …
Read moreZBM recognised in the IAM European Patent Office (EPO) Patent rankings 2022
Alongside the continual recognition ZBM receives annually from the Managing Intellectual Property IPStars and the Intellectual Asset Management magazine (IAM)…
Read moreTwo New European Patent Attorneys on the ZBM Team
We are delighted to announce that two of our team members Javier Ferrandis (MSc Control Systems and Industrial…
Read moreProtecting amino acid and nucleic acid sequence variants
The great success of biologics —drugs produced from living organisms or that contain components of living organisms— over the last…
Read moreHow to improve (delay) the national/regional phase entry of a PCT application
The PCT application became a reality in 1978. In the same year it was also possible to apply for European…
Read morePerformance of ZBM Patents & Trademarks in opposition and appeal proceedings before the EPO
Since the work of oppositions and appeal in the European Patent Office (EPO) is highly specialized and challenging, we have…
Read more“PCT DIRECT a great tool in patent prosecution strategy”
Many applicants file an international application (PCT) in the priority year to, among other reasons, delay the costs associated with…
Read moreOral proceedings by videoconference at the EPO, are they here to stay?
The European patent opposition procedure is a fundamental tool to balance the interests of patent holders and third parties.
Most of…
Read more